It was reported that the vad coordinator (vc) reported to the clinician that the patient was complaining of feeling palpitations that correlated with the "the wash out/pulsatility of the heartmate 3." the vc noted that while auscultating, the vibration feeling that the patient reported appeared to correspond with the "wash out/pulsatility" of the pump.The clinical recommended sending log files to be reviewed.The vc also reported the potential need to ensure proper pump positioning with imaging as well as investigating lack of interference from the patient's implantable cardioverter-defibrillator (icd).Per the vc, the pump appears to be operating without any issues and the patient is clinically stable at home.It was additionally reported on 14dec2020 that when the customer referred to the washout/pulsatility of the pump, they were referring to the occurrence of pump speed changes.No images have been acquired to rule out improper positioning of the pump and no interference between the implantable cardioverter-defibrillator (icd) and the lvad system has been confirmed.The patient did receive a shock from their icd during this event.It was additionally reported that the patient's icd was implanted prior to vad to treat ventricular tachycardia.
|
Manufacturer's investigation conclusion: a direct correlation between heartmate 3 left ventricular assist system (lvas), serial number (b)(6), and the reported event could not conclusively be established through this evaluation.Furthermore, a specific cause for the event could not be determined.The patient remains ongoing on heartmate 3 lvas, serial number (b)(6).No further related events have been reported at this time.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The relevant sections of the device history records for the percutaneous lead were also reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped on 22jun2017.The heartmate 3 left ventricular assist system (lvas) instructions for use (ifu) is currently available.Section 1 of this document lists cardiac arrhythmia as an adverse event that may be associated with the use of the heartmate 3 lvas.Section 6 entitled ¿patient care and management¿ also lists arrhythmia as a potential late postimplant complication.Section 1, ¿introduction¿, and section 6, ¿patient care and management¿, instruct the user to notify appropriate personnel if there is a change in how the pump works, sounds, or feels.Section 5 "surgical procedures" explains how to insert the pump in the ventricle and instructs the user to take care to avoid orienting the inlet towards the interventricular septum as pump function will be compromised in the presence of inlet obstruction.The steps to adjust the orientation of the pump are also outlined in this section.Section 1 "introduction", section 5 "surgical procedures", and section 6 "patient care and management" warn the user: the heartmate iii pump may cause interference with automated implantable cardioverter defibrillators (aicds).If electromagnetic interference occurs it may lead to inappropriate aicd therapy.The occurrence of electromagnetic interference with aicd sensing may require adjustment of device sensitivity and/or repositioning the lead." sections 5 and 6 additionally warns the user: prior to implanting an implantable cardiac defibrillator (icd) or implantable pacemaker (ipm) in a heartmate iii patient, the device to be implanted should be placed in close proximity to the pump (approximately 10 cm) and the telemetry verified.If a patient receives a heartmate iii and has a previously implanted device that is found to be susceptible to electromagnetic interference which could affect programming, the manufacturer recommends replacing the icd or ipm device with one that is not prone to programming interference.Section b "safety testing and classification" states: the heartmate iii left ventricular assist system has been tested and found to comply with the limits for medical devices to the international electrotechnical commission (iec).These limits are designed to provide reasonable protection against harmful interference in a typical medical installation.The heartmate iii left ventricular assist system can generate, use, and radiate radio frequency energy and, if not installed and used in accordance with the instructions, may cause harmful interference to other devices in the vicinity.However, there is no guarantee that interference will not occur in a particular installation.If this equipment does cause harmful interference to other devices, the user is encouraged to try to correct the interference by one or more of the following measures: reorient or relocate the equipment, increase the separation between the equipment, connect the equipment into an outlet on a circuit different from that to which the other device(s) are connected, consult the manufacturer for assistance.Note: special precautions are required for installing and using the heartmate iii left ventricular assist system within portable and rf communication environments.No further information was provided.The manufacturer is closing the file on this event.
|